Cargando…
The authors respond to “Concerns about subgroup analyses and reason for stopping remdesivir trial”
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
CMA Impact Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920528/ https://www.ncbi.nlm.nih.gov/pubmed/35288413 http://dx.doi.org/10.1503/cmaj.81278 |
_version_ | 1784669147095891968 |
---|---|
author | Murthy, Srinivas |
author_facet | Murthy, Srinivas |
author_sort | Murthy, Srinivas |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8920528 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | CMA Impact Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89205282022-03-18 The authors respond to “Concerns about subgroup analyses and reason for stopping remdesivir trial” Murthy, Srinivas CMAJ Letters CMA Impact Inc. 2022-03-14 2022-03-14 /pmc/articles/PMC8920528/ /pubmed/35288413 http://dx.doi.org/10.1503/cmaj.81278 Text en © 2022 CMA Impact Inc. or its licensors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/ |
spellingShingle | Letters Murthy, Srinivas The authors respond to “Concerns about subgroup analyses and reason for stopping remdesivir trial” |
title | The authors respond to “Concerns about subgroup analyses and reason for stopping remdesivir trial” |
title_full | The authors respond to “Concerns about subgroup analyses and reason for stopping remdesivir trial” |
title_fullStr | The authors respond to “Concerns about subgroup analyses and reason for stopping remdesivir trial” |
title_full_unstemmed | The authors respond to “Concerns about subgroup analyses and reason for stopping remdesivir trial” |
title_short | The authors respond to “Concerns about subgroup analyses and reason for stopping remdesivir trial” |
title_sort | authors respond to “concerns about subgroup analyses and reason for stopping remdesivir trial” |
topic | Letters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920528/ https://www.ncbi.nlm.nih.gov/pubmed/35288413 http://dx.doi.org/10.1503/cmaj.81278 |
work_keys_str_mv | AT murthysrinivas theauthorsrespondtoconcernsaboutsubgroupanalysesandreasonforstoppingremdesivirtrial AT murthysrinivas authorsrespondtoconcernsaboutsubgroupanalysesandreasonforstoppingremdesivirtrial |